NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Kim N Chi
British Columbia Cancer Agency - Vancouver / Canada
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4375088
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Kim N Chi's MOST POPULAR ARTICLES
1-)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancerIF Tannock, R De Wit, WR Berry, J Horti, A Pluzanska, KN Chi, S Oudard, ...New England Journal of Medicine 351 (15), 1502-1512, 200467292004
2-)
Increased survival with enzalutamide in prostate cancer after chemotherapyHI Scher, K Fizazi, F Saad, ME Taplin, CN Sternberg, K Miller, R De Wit, ...New England Journal of Medicine 367 (13), 1187-1197, 201247312012
3-)
Abiraterone and increased survival in metastatic prostate cancerJS De Bono, CJ Logothetis, A Molina, K Fizazi, S North, L Chu, KN Chi, ...New England Journal of Medicine 364 (21), 1995-2005, 201147192011
4-)
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results from a large …DYC Heng, W Xie, MM Regan, MA Warren, AR Golshayan, C Sahi, ...Journal of clinical oncology 27 (34), 5794-5799, 200923082009
5-)
Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancerK Fizazi, NP Tran, L Fein, N Matsubara, A Rodriguez-Antolin, ...New England Journal of Medicine 377 (4), 352-360, 201721652017
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept